Alemtuzumab for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, April 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

blogs: 1 blog
twitter: 6 tweeters
patent: 2 patents

facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 188 Mendeley

Summary Blogs Twitter Patents Facebook Wikipedia Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

Alemtuzumab for multiple sclerosis

Article in Cochrane Database of Systematic Reviews (June 2023)

Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results

Article in Multiple Sclerosis and Related Disorders (March 2023)

Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease

Article in CNS Drugs (January 2023)